ABSTRACT: Background. The purpose of this study was to evaluate prospectively the presence and impact of the gastric carcinogen Helicobacter pylori (H. pylori) in the upper aerodigestive tract. Previous studies suggested it could represent a risk factor for head and neck squamous cell carcinoma (HNSCC). Methods. Serology, rapid urease test, and quantitative polymerase chain reaction (qPCR) for H. pylori were performed in patients with head and neck cancer (N 5 56) and cancer-free controls (N 5 90). Comparison between groups was done using logistic regression analysis. Results. Rates of positive serology and rapid urease test did not differ between the 2 groups in logistic regression analysis (p 5 .677 and p 5 .633, respectively). Birth in a developing country and age above 50 years old were predictors of positive serology (p <
INTRODUCTION
Helicobacter pylori (H. pylori) is a spiral-shaped gramnegative bacterium discovered by Marshall and Warren in 1984 . 1 It is recognized as an etiological agent of gastric cancer by the World Health Organization 2 and represents one of the most common infections worldwide. 3 The prevalence of H. pylori varies strongly between populations, being much higher in developing countries. Proposed risk factors include low socioeconomic status, increasing age, tobacco use, and infection of siblings. 3 The dominant infection route still remains controversial, whereas a human-to-human transmission seems probable. 3 H. pylori containing liquids are thought to infect new individuals orally, implying that H. pylori must be transiently present in the upper aerodigestive tract (UADT). 3 The presence and potential impact of H. pylori in the UADT is subject to debate. 4, 5 H. pylori has not only been associated with inflammatory conditions, which include aphthous ulcers, 6, 7 chronic pharyngitis, 8 and dental plaques, 9,10 but also with malignancy, such as head and neck squamous cell carcinoma (HNSCC). [11] [12] [13] [14] [15] [16] In a previous retrospective pilot study using conventional polymerase chain reaction (PCR), we described that H. pylori can be found in the UADT of 38% of patients with proven gastric colonization. 17 Willing to validate the results of our pilot study, we conducted a prospective study combining serology, rapid urease test, and quantitative PCR (qPCR). A positive rapid urease test combined with a positive qPCR would indicate the presence of viable H. pylori, which would be confirmed by a positive serology. The primary purposes of the study were to assess if H. pylori could be found in UADT samples of an unselected cohort of patients, and, if so, would be found more frequently among patients with HNSCC. The latter would imply a potential carcinogenic role for H. pylori outside of the stomach.
PATIENTS AND METHODS
After local ethics review board approval, we prospectively enrolled inpatients at the Department of Otolaryngology -Head and Neck Surgery of the University Hospital Zurich, Switzerland, from March 1, 2012, to September 30, 2012 . Two groups of patients were included: the tumor group with patients undergoing panendoscopy for HNSCC, and the control group with patients undergoing tonsillectomy, thyroidectomy, parotidectomy, or endoscopy for benign disease. All patients received an information form detailing the design and purpose of the study. The first author (G.B.M.) was then responsible for discussing and settling any questions with the patients. After signing the informed consent form, the patients completed a survey to assess for their country of birth, tobacco use, alcohol consumption, and gastroesophageal reflux. Tobacco use was defined as a current daily consumption of cigars or cigarettes. Alcohol consumption was defined as a daily intake of more than 20 grams of ethanol at least 5 days a week. Gastroesophageal reflux was defined as troublesome heartburn occurring 2 days or more every week. 18 Exclusion criteria were age <18 years, history of H. pylori eradication, and previous radiation in the head and neck area.
A blood sample was drawn from each patient the day before surgery and sent for serologic examination using VIDAS H. pylori Ig6 EIA (BioM erieux, Marcy l'Etoile, France); the test was performed in accord with the manufacturer's instructions; the results were categorized as positive, negative, or indeterminate. During surgery, a mucosal specimen was obtained in the tumor group from the tumor and from the surrounding healthy appearing tissue. The latter is further referred to as peritumoral. Peritumoral samples were taken approximately 1 cm away from the macroscopic tumor. In the control group, a sample was taken from the tonsillar surface in patients undergoing tonsillectomy. In the remainder of the control group, a biopsy was taken from the buccal mucosa. After the operation, all samples were divided into 2 aliquots. The first part was used to perform a rapid urease test (Prontodry, Medisafe, Hamburg, Germany) in accord with the manufacturer's instructions. The second part was stored in Allprotect Tissue Reagent (Qiagen, Hombrechtikon, Switzerland) and frozen at 220 C until qPCR was performed (see Figure 1 ).
Quantitative polymerase chain reaction
After genomic DNA isolation according to Secka et al, 19 qPCR was performed with Rotorgene 6000 (Qiagen, Hombrechtikon, Switzerland) with 25 ng of each isolate. Dissociation and standard curves for all primers were generated. Quality control was carried out as recommended by MIQE Guidelines. 20 The reactions were carried out in triplicate for H. pylori on the ureA gene according to Schabereiter-Gurtner et al 21 (77-bp PCR product size; forward 5 0 -CGT GGC AAG CAT GAT CC AT-3 0 ; reverse 5 0 -GGG TAT GCA CGG TTA CGA GT TT-3 0 ). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as endogenous control (216-bp PCR product size; forward 5 0 -AGG GCC CTG ACA ACT CTT TT; reverse 5 0 -AGG GGA GAT TCA GTG TGG TG). GAPDH reactions were run in parallel to each ureA reaction to exclude PCR inhibition.
An external positive control was obtained using a stomach biopsy, for which H. pylori culture and histopathological staining were positive (courtesy of Ch. Gubler, MD, Clinic of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland). Amplification occurring after threshold cycle (C t ) 35 and inconsistent among technical replicates was considered a false-positive result. 22 The genomic DNA isolation and qPCR were performed by Microsynth, Balgach, Switzerland, who were blinded on study group allocation and preliminary results.
Statistical analysis
For dichotomous variables, the 2-sided chi-square test was used to compare proportions and /-coefficient for correlations. For discrete variables showing normal distribution, means and SDs are given. Alternatively, median, first quartile (Q25), and third quartile (Q75) are indicated. For comparison of means, the t test was used. Odds ratio (OR) and 95% confidence interval (95% CI) were calculated according to the Mantel-Haenzel method. A multivariate binary logistic regression model was used to compare the study groups after adjusting for significant variables. A parsimonious model was obtained by backward elimination of irrelevant variables. For serology, analyses were always made twice, once assuming indeterminate cases to be positive, and once to be negative. If not specified otherwise, the results of the alternate assumption did not differ significantly and are shown for the positive assumption.
An a priori power analysis was conducted with a power value of 80% and 2-sided confidence level of 0.95. According to the available literature, 23 we assumed a prevalence of approximately 30% in the tumor group and 10% in the control group, with a 2:3 ratio between the tumor group and the control group, and obtained a sample size of 50 and 75, respectively.
Statistical analyses were performed using SPSS v 21.0.0 software (IBM, Armonk, NY) with the help of a biostatistician (see acknowledgments).
RESULTS
In total, 146 patients were included in the study. Baseline demographic data for the tumor group and control group are summarized in Table 1 . A positive enzyme-linked immunosorbent assay reaction from the blood sample was considered as positive serology. A mucosal fragment eliciting a color change was considered a positive rapid urease test. For qPCR, amplification had to occur in all 3 technical replicates and before C t 5 35 to be considered positive (for details see Patients and Methods). Rapid urease test and qPCR results for tumor and peritumoral biopsy did not differ notably (data not shown). Results from serology, rapid urease test, and qPCR were available for 133, 96, and 101 subjects, respectively. In univariate analysis, positive serology and rapid urease test did not differ significantly between the tumor group and the control group (Table 2) . For qPCR, none of the samples were positive. Specifically, none of them showed amplification for the H. pylori specific gene ureA, whereas the endogenous positive control for GAPDH and the external positive control were clearly positive at mean threshold cycle (C t ) of 22.3 (SD 5 1.79) and mean C t of 28.5 (SD 5 0.04), respectively.
Using a logistic regression model controlling for potential confounding variables, no differences were seen for positive serology and positive rapid urease tests between the 2 groups (p 5 .677 and p 5 .633, respectively). The variable "birth in a developing country" showed a highly significant relation with positive serology (p < .001) in both univariate and multivariate analysis. Age above 50 years old also showed to be an independent predictor of positive serology in multivariate analysis. The other variables -sex, smoking, alcohol consumption, and gastroesophageal reflux -were not significantly associated with positive serology (Table 3) . A positive rapid urease test did not show any significant association with any of the variables (not shown). The correlation between serology and rapid urease test was weak and did not reach statistical significance (phi 5 0.177; p 5 .10).
DISCUSSION
In a previous retrospective pilot study using conventional PCR, we found that 38% of patients with proven gastric colonization had presence of H. pylori in the UADT. An association with malignancy could not be detected, nevertheless the study dealt with a small sample of patients. 17 Acknowledging the limitations of our pilot study and willing to validate its findings, we conducted this prospective comparative study using qPCR, rapid urease test, and serology.
Overall, we found H. pylori serology to be positive in approximately one third of our patients, which is comparable to data from other Western countries. 3 Patients with head and neck cancer were not more likely to have positive serology than the controls, in both univariate and logistic regression analysis. This result does not support an association of H. pylori with HNSCC and is consistent with other serologic studies. [24] [25] [26] Two studies, however, reported H. pylori positive serology to be more frequent among patients with head and neck cancer. Both of them compared cancer-free controls to with patients with laryngeal or hypopharyngeal cancer.
11,12 The first study reported that H. pylori positive serology was associated with an OR almost 4 times greater than smoking in patients with head and neck cancer, suggesting unassessed confounding. 11 A potential confounder omitted in their multivariate regression analysis was increasing age, which is considered a risk factor for positive serology 3 and showed uneven distribution between the study groups (p 5 .05). 11 The second study did not perform multivariate analysis, and used the chi-square method, although of a limited sample size. Both factors render the interpretation of their results difficult. 12, 27 In our study, the only demographic variables significantly associated with a positive serology were birth in a developing country and increasing age, which is in accordance with epidemiologic data. 3 Rapid urease test was frequently positive in our study. However, the correlation between a positive urease test and positive serology was weak. This is presumably because of the urease activity of bacteria other than H. pylori residing in the UADT, leading to nonspecific positive rapid urease test. 4 Previous studies also reported low specificity of this test for extragastric samples. 28 Therefore, rapid urease test results from the UADT should be interpreted as "indicative of viable H. pylori" only if good concordance with serology and/or PCR can be observed.
Because H. pylori PCR can yield high false-positive rates when performed on extragastric samples, 21, 29 major attention was dedicated to the design of the qPCR experiment. We chose to use a validated qPCR protocol for extragastric samples, as described by Schabereiter-Gurtner et al. 21 This protocol is highly specific as the target gene -ureA -was shown to have 100% homology with H. pylori genome only. It is also very sensitive because it can amplify bacterial DNA until 4 fg of DNA (4 3 10 215 g), which is equivalent to approximately 2.2 microorganisms. 21 Using this method, we failed to show ureA amplification in any of our test samples. This strongly suggests that H. pylori was not present in the UADT biopsy samples at the time of the biopsy. In the literature, reported PCR detection rates for H. pylori in the UADT range from 0% 5, 30 to 100% 16 in adults, with most studies situated between these 2 extremes. [13] [14] [15] [16] [17] 31 Many factors may be responsible for this discrepancy: first, the targeted genes and primers used to detect H. pylori vary widely. It was shown that some commonly used primers may not be fully specific, as they show complementarity with genomes of bacterial species other than H. pylori. 21 Second, even though specific PCR amplification proves that H. pylori DNA is present, it does not allow any conclusion on the viability of H. pylori. In fact, positive H. pylori culture has very rarely been reported in studies testing UADT samples, even if they showed high rates of positive PCR. 14, 31 Third, it should be noted that studies with high PCR detection rates were mostly conducted in developing countries, where environmental exposure to H. pylori is higher. 32 Whether higher detection rates could also be explained by catching in-transit bacteria is yet to be elucidated.
H. pylori bacteria may also be detected in the UADT because of gastric contamination. 33 H. pylori-contaminated gastric fluids may reach the UADT in a retrograde fashion and lead to positive PCR results in the UADT. Gastroesophageal reflux and supine position would presumably encourage this phenomenon. 33 This factor could explain the apparent discrepancy with our pilot study, in which we amplified H. pylori DNA by PCR in 38% of the patients testing UADT samples. 17 Unlike the present study conducted in a collective of patients with head and neck with unknown H. pylori infection status, our pilot study only included patients with H. pylori-positive gastritis and coincidental UADT biopsy. Our database contained 2830 H. pylori-positive gastric biopsies, yet only 26 patients met the inclusion criteria of the pilot study. 17 A larger collective of unselected patients in the present study may have resulted in few incidental individuals with active H. pylori gastric infection -and UADT contamination -leading to a few positive qPCRs.
On a final note, we compared our results to the literature concerning esophageal carcinoma, for which H. pylori infection was shown to be a protective factor. 34 The inverse relation between esophageal cancer and H. pylori is thought to result from lower acidic gastric secretion -a consequence of H. pylori infection -and hence diminished chronic irritation of the esophageal mucosa. 35 Because HNSCC shares many common etiological features with esophageal squamous cell carcinoma, a positive relation between H. pylori infection and head and neck cancer seems unlikely. 36 Interestingly, the literature assessing the role of H. pylori in esophageal cancer does not imply the presence of H. pylori in the esophagus but investigates the remote effect of gastric H. pylori infection on the esophageal mucosa. 34 Even in the assumption that H. pylori may be present in the UADT, it is questionable whether H. pylori can survive long enough outside the stomach to significantly impact carcinogenesis. Chronic inflammation in the stomach, a significant pathway leading to gastric cancer, 37 was shown to correlate consistently with bacterial loads of H. pylori.
38
In summary, our study provides evidence that H. pylori is not found frequently in the upper aerodigestive tract of a nonselected Western population of patients with head and neck cancer. Furthermore, we did not find patients with head and neck cancer to show more likely H. pylori positive serology than cancer-free controls. Finally, the rapid urease test showed nonspecific results and should not be used alone for assessing extragastric samples. Although we do not believe that H. pylori is a major risk factor for HNSCC, further studies considering patients without history of nicotine consumption, alcohol use, and negative human papillomavirus status could be of interest, particularly in populations from developing countries.
